231
Participants
Start Date
February 28, 2006
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027)
1 pill per day taken orally over 7 cycles of 28 pills per cycle
Placebo
1 pill per day taken orally over 7 cycles of 28 pills per cycle
University of Semmelweis, Budapest
Center for Clinical& Basic Research, Pardubice
Selya Janos Hospital, Komárom
Borsod-Abauj-Zemplen County Hospital, Miskolc
King Edward Memorial Hospital, Subiaco
PreCare Trial & Recruitment, Geleen
emovis GmbH, Berlin
Terveystalo Lahti, Lahti
Ylioppilaiden terveydenhoitosäätiö, Turku, Turku
Skånes Universitetssjukhus, Lund
Praxis Hr. Dr. K. Greven, Hanover
Koskiklinikka, Tampere
Gynekologicka ambulance Vanda Horejsi, MD, České Budějovice
Gynekologicko-poradnicka ambulance Dr. Hlavackova, Písek
Praxis Hr. Dr. U. Kohoutek, Karlsruhe
Praxis Hr. Dr. S. Schönian, Rheinstetten
Private Practice Dr. Ian Fraser, Ashfield
Lekarsky dum Praha 7 a.s.Gynekologicka ambulance Dr. Jenicek, Prague
Adenova Lääkärikeskus Oy, Espoo
ClinPharm International GmbH, Dresden
Medisch Spectrum Twente, Locatie Ariensplein, Enschede
Menox BV, Nijmegen
Poliklinika Ginekologiczna- Poloznicza, Bialystok
Instytut Centrum Zdrowia Matki Polki, Lodz
SPSK nr 1, Lublin
Szpital Kliniczny nr 3, Poznan
CSK MSWiA, Warsaw
Karolinska Universitetssjukhuset Huddinge, Stockholm
Akademiska Sjukhuset, Uppsala
Dept. of obstetrics and gynaecology, Kiev
Instr. of Pediatrics, Obstetrics & Gynecology, Kiev
Kyiv Medical Academy of Postdyploma Education, Kiev
Lviv Regional Center Perinatal Center, Lviv
Bridge House Medical Centre, Cheadle
Luton & Dunstable Hospital, Luton
MeDiNova Research, Northwood
Lead Sponsor
Bayer
INDUSTRY